Click here for the most current list of our publications.

Robbins DJ, Pavletich TS, Patil AT, Pahopos D, Lasarev M, Polaki US, Gahvari ZJ, Bresnick EH, Matson DR. Linking GATA2 to Myeloid Dysplasia and Complex Cytogenetics in Adult Myelodysplastic Neoplasm and Acute Myeloid Leukemia. Blood Advances. Accepted.

Rajagopalan A, Feng Y, Gayatri MB, Ranheim EA, Klungness T, Matson DR, Lee MH, Jung MM, Zhou Y, Gao X, Nadiminti KV, Yang DT, Tran VL, Padron E, Miyamoto S, Bresnick EH, Zhang J. A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice. J Clin Invest. 2023 Oct 17:e173116. Epub ahead of print.

Tavberidze N, Bennett DD, Matson DR. Diffuse Large B-Cell Lymphoma, Not Otherwise Specified (DLBCL NOS) Presenting as Multiple Subcutaneous Nodules: An Unusual Cutaneous Presentation of Systemic Disease. Case Reports in Pathology. 2023 Oct 3;2960965.

Patil AT, Bennett DD, Xu J, Weisman P, Matson DR. Spatial transcriptomics of a giant pilomatricoma. J Cutan Pathol. 2023 Aug.

Reinig EF, Rubinstein JD, Patil AT, Schussman AL, Horner VL, Kanagal-Shamanna R, Churpek JE, Matson DR. Needle in a haystack or elephant in the room? Identifying germline predisposition syndromes in the setting of a new myeloid malignancy diagnosis. Leukemia. 2023 Aug;37(8):1589-1599.

Matson DR, Matkovic E. Peripheral erythrophagocytosis in paroxysmal cold hemoglobinuria. Blood. 2023 Mar 9;141(10):1233.

Janczyk PŁ, Żyłkiewicz E, De Hoyos H, West T, Matson DR, Choi WC, Young HMR, Derewenda ZS, Stukenberg PT. Aurora A phosphorylates Ndel1 to reduce the levels of Mad1 and NuMA at spindle poles. Mol Biol Cell. 2023 Jan 1;34(1).

Kim JA, Shen S, Matson DR, Lovrien LN, Smith-Simmer KJ, Keles S, Churpek JE, Bresnick EH. Discriminating activities of DEAD-Box Helicase 41 from myeloid malignancy-associated germline variants by genetic rescue. Leukemia. 2023 Jan;37(1)

Li L, Kim JH, Lu W, Williams DM, Kim J, Cope L, Rampal RK, Koche RP, Xian L, Luo LZ, Vasiljevic M, Matson DR, Zhao ZJ, Rogers O, Stubbs MC, Reddy K, Romero AR, Psaila B, Spivak JL, Moliterno AR, Resar LMS. HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression. Blood. 2022 May 5;139(18):2797-2815.

Soukup AA, Matson DR, Liu P, Johnson KD, Bresnick EH. Conditionally pathogenic genetic variants of a hematopoietic disease-suppressing enhancer. Sci Adv. 2021 Dec 10;7(50).

Matson DR, Accola MA, Henderson L, Shao X, Frater-Rubsam L, Horner VL, Rehrauer WM, Weisman P, Xu J. A “Null” Pattern of p16 Immunostaining in Endometrial Serous Carcinoma: An Under-recognized and Important Aberrant Staining Pattern. Int J Gynecol Pathol. 2021 Aug 11.

Mehta C, Fraga de Andrade I, Matson DR, Dewey CN, Bresnick EH. RNA-regulatory exosome complex confers cellular survival to promote erythropoiesis. Nucleic Acids Res. 2021 Sep 20;49(16):9007-9025.

Smeenk L, Ottema S, Mulet-Lazaro R, Ebert A, Havermans M, Arricibita Varea A, Fellner M, Pastoors D, van Herk S, Erpelinck-Verschueren C, Grob T, Hoogenboezem RM, Kavelaars FG, Matson DR, Bresnick EH, Bindels EM, Kentsis A, Zuber J, Delwel R. Selective requirement of MYB for oncogenic hyperactivation of a translocated enhancer in leukemia. Cancer Discov. 2021 May 12.

Pritzl SL, Matson DR, Juckett MB, Ciske DJ. 2021. Concurrent Central Diabetes Insipidus and Acute Myeloid Leukemia. Case Rep Hematol. 16;2021 eCollection.

Matson DR, Denu RA, Zasadil LM, Burkard ME, Weaver BA, Flynn C, Stukenberg PT. 2021 High nuclear TPX2 expression correlates with TP53 mutation and poor clinical behavior in a large breast cancer cohort, but is not an independent predictor of chromosomal instability. BMC Cancer. 23;21(1):186.

Ray S, Chee L, Matson DR, Palermo NY, Bresnick EH, Hewitt KJ. 2020. Sterile α-motif domain requirement for cellular signaling and survival. Journal of Biological Chemistry. 15;295(20):7113-7125.

Matson DR & Yang DT. 2020. Autoimmune lymphoproliferative syndrome – An overview. Archives of Pathology and Laboratory Medicine. 144(2):245-251.

Denu RA, Matson DR, Davis MJ, Tedford NJ, Brichta CE, Diamond CA, Hoover-Regan ML. 2019. Association of Immune Thrombocytopenia and T-Lymphoblastic Lymphoma in a Pediatric Patient. Case Reports in Hematolology. 2019:1425151.

Mushtaq MU & Matson DR. 2019. Simultaneous acute myeloid leukemia, multiple myeloma and amyloidosis. Blood. 134(15):1270.

Castaño J, Aranda S, Bueno C, Calero-Nieto FJ, Mejia-Ramirez E, Mosquera JL, Blanco E, Wang X, Prieto C, Zabaleta L, Mereu E, Rovira M, Jiménez-Delgado S, Matson DR, Heyn H, Bresnick EH, Gӧttgens B, Croce LD, Menendez P, Raya A, Giorgetti A. 2019. GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm. Stem Cell Reports. 13(3):515-529.

Matson DR, Accola MA, Rehrauer WM, Corliss RF. 2018. Fatal myocarditis following treatment with the PD-1 inhibitor nivolumab. J Forensic Sci. 63(3):954-957.

Matson DR, Accola MA, Rehrauer WM, Huang W. 2018. An atypical case of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma identified by next-generation sequencing. Hum Path: Case Rep. 11:1-5.

Matson DR, Hardin H, Buehler D, Lloyd RV. 2017. AKT activity is elevated in aggressive thyroid neoplasms where it promotes proliferation and invasion. Exp Mol Pathol. 103(3):288-293.

Bailey AL, Buechler CR, Matson DR, Peterson EJ, Brunner KG, Mohns MS, Breitbach M, Stewart LM, Ericsen AJ, Newman CM, Koenig MR, Mohr E, Tan J, Capuano S 3rd, Simmons HA, Yang DT, O’Connor DH. 2017. Pegivirus avoids immune recognition but does not attenuate acute-phase disease in a macaque model of HIV infection. PLoS Pathog. 13(10):e1006692.

Hewitt KJ, Katsumura KR, Matson DR, Devadas P, Tanimura N, Hebert AS, Coon JJ, Kim J, Dewey CN, Keles S, Hao S, Paulson RF, Bresnick EH. 2017. GATA factor-regulated Samd14 enhancer confers red blood cell regeneration and survival in severe anemia. Dev Cell. 42(3):213-225.

Janczyk PL, Skorupka KA, Tooley JG, Matson DR, Kestner CA, West T, Pornillos O, Stukenberg PT. 2017. Mechanism of Ska recruitment by Ndc80 complexes to kinetochores. Developmental Cell. 41(4):438-449.

Matson DR, Xu J, Huffman L, Barroilhet L, Accola M, Rehrauer WM, Weisman P. 2017. KRAS and GNAS co-mutation in metastatic low-grade appendiceal mucinous neoplasm (LAMN) to the ovaries: A practical role for next-generation sequencing. Am J of Case Reports. 18:558-562.

Katsumura KR, Gao X, Hewitt KJ, Matson DR, McIver SC, Mehta CH, Soukup AA, Tanimura N, Shi L, Johnson KD, Bresnick EH. 2017. The GATA factor revolution in hematology. Blood. 129(15):2092-2102.

Matson DR, Stukenberg PT. 2014. CENP-I and Aurora B act as a molecular switch that ties RZZ/Mad1 recruitment to kinetochore attachment status. J Cell Biology. 205(4):541-554.

Alushin GM, Musinipally V, Matson DR, Tooley J, Stukenberg PT, Nogales E. 2012. Multimodal microtubule binding by the Ndc80 kinetochore complex. Nature Structural & Molecular Biology. 19(11):1161-1167.

Matson DR, Stukenberg PT. 2012. Cdt1 throws kinetochore-microtubule attachments for a loop. Nature Cell Biology. 14(6):561-563.

Matson DR, Demirel PB, Stukenberg PT, Burke DJ. 2012. A conserved role for COMA/CENP-H/I/N kinetochore proteins in the spindle checkpoint. Genes & Development. 26(6):542-547.

Matson DR, Stukenberg PT. 2011. Spindle poisons and cell fate: a tale of two pathways. Molecular Interventions. 11(2):141-150.

Matson DR, Eudy JD, Matson SC. 2010. Cutaneous alternariosis in an adolescent patient. Pediatric Dermatology. 27(1):98-100.

Yi XY, Li VX, Zhang F, Yi F, Matson DR, Jiang MT, Li PL. 2006. Characteristics and actions of NAD(P)H oxidase on the sarcoplasmic reticulum of coronary artery smooth muscle. Am J Physiol. 290(3):H1136-1144.